P. Jaquet
Interactions Cellulaires Neuroendocrines
UMR 6544
Centre National de la Recherche Scientifique
Institut Fédératif Jean Roche
France
Name/email consistency: high
- Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy. Jaquet, P., Gunz, G., Saveanu, A., Dufour, H., Taylor, J., Dong, J., Kim, S., Moreau, J.P., Enjalbert, A., Culler, M.D. Eur. J. Endocrinol. (2005)
- New SRIF analogs in the control of human pituitary adenomas: perspectives. Jaquet, P., Saveanu, A., Barlier, A. J. Endocrinol. Invest. (2005)
- BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide. Jaquet, P., Gunz, G., Saveanu, A., Barlier, A., Dufour, H., Taylor, J., Dong, J., Kim, S., Moreau, J.P., Culler, M.D. J. Endocrinol. Invest. (2005)
- Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes. Jaquet, P., Saveanu, A., Gunz, G., Fina, F., Zamora, A.J., Grino, M., Culler, M.D., Moreau, J.P., Enjalbert, A., Ouafik, L.H. J. Clin. Endocrinol. Metab. (2000)
